Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $636.33 | 31 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $264.32 | 10 | $0 (2019) |
| Vanda Pharmaceuticals Inc. | $148.55 | 6 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $52.17 | 4 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $28.59 | 2 | $0 (2019) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $26.54 | 2 | $0 (2019) |
| Allergan Inc. | $24.30 | 2 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.33 | 1 | $0 (2019) |
| Vertical Pharmaceuticals, LLC | $20.77 | 1 | $0 (2019) |
| PFIZER INC. | $18.99 | 1 | $0 (2017) |
| Neurocrine Biosciences, Inc. | $17.46 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $511.51 | 22 | Janssen Pharmaceuticals, Inc ($264.32) |
| 2018 | $71.62 | 5 | Neurocrine Biosciences, Inc. ($17.46) |
| 2017 | $53.20 | 4 | Sunovion Pharmaceuticals Inc. ($20.90) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $9.67 | General |
| Category: Neuroscience | ||||||
| 12/06/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $1.70 | General |
| Category: Neuroscience | ||||||
| 11/15/2019 | Vanda Pharmaceuticals Inc. | Fanapt (Drug), Hetlioz | Food and Beverage | In-kind items and services | $26.95 | General |
| Category: Schizophrenia | ||||||
| 10/21/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: Neuroscience | ||||||
| 10/11/2019 | Vanda Pharmaceuticals Inc. | Fanapt (Drug), Hetlioz | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Schizophrenia | ||||||
| 09/27/2019 | Vanda Pharmaceuticals Inc. | Fanapt (Drug), Hetlioz | Food and Beverage | In-kind items and services | $25.82 | General |
| Category: Schizophrenia | ||||||
| 09/07/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Neuroscience | ||||||
| 08/23/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Vyvanse (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Central Nervous System (CNS) | ||||||
| 08/16/2019 | Vanda Pharmaceuticals Inc. | Fanapt (Drug), Hetlioz | Food and Beverage | In-kind items and services | $31.47 | General |
| Category: Schizophrenia | ||||||
| 08/09/2019 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: PSYCHIATRY | ||||||
| 08/02/2019 | Vertical Pharmaceuticals, LLC | RELEXXII (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: ADHD | ||||||
| 07/12/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: CNS | ||||||
| 06/28/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Neuroscience | ||||||
| 06/22/2019 | Vanda Pharmaceuticals Inc. | Fanapt (Drug), Hetlioz | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: Schizophrenia | ||||||
| 06/01/2019 | Vanda Pharmaceuticals Inc. | Fanapt (Drug), Hetlioz | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Schizophrenia | ||||||
| 05/31/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: Neuroscience | ||||||
| 04/26/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Neuroscience | ||||||
| 03/22/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Neuroscience | ||||||
| 03/20/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $121.63 | General |
| Category: Neuroscience | ||||||
| 03/01/2019 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $13.15 | General |
| 02/14/2019 | Janssen Pharmaceuticals, Inc | — | Food and Beverage | In-kind items and services | $8.89 | General |
| 01/18/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.08 | General |
| Category: NEUROSCIENCE | ||||||
| 12/07/2018 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: NEUROLOGY | ||||||
| 10/12/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: NEUROSCIENCE | ||||||
| 05/18/2018 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $13.39 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 108 | 392 | $48,300 | $23,985 |
| 2022 | 2 | 166 | 256 | $34,182 | $18,395 |
| 2021 | 2 | 96 | 232 | $22,143 | $16,190 |
| 2020 | 1 | 105 | 327 | $25,869 | $16,020 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 88 | 371 | $44,520 | $22,410 | 50.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 21 | $3,780 | $1,574 | 41.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 81 | 168 | $18,763 | $10,357 | 55.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 85 | 88 | $15,419 | $8,038 | 52.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 71 | 195 | $17,456 | $12,733 | 72.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 25 | 37 | $4,687 | $3,456 | 73.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 105 | 327 | $25,869 | $16,020 | 61.9% |
About Dr. John Erhart, MD
Dr. John Erhart, MD is a Psychiatry healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487714960.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Erhart, MD has received a total of $636.33 in payments from pharmaceutical and medical device companies, with $511.51 received in 2019. These payments were reported across 31 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($636.33).
As a Medicare-enrolled provider, Erhart has provided services to 475 Medicare beneficiaries, totaling 1,207 services with total Medicare billing of $74,589. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Rochester, NY
- Active Since 12/12/2006
- Last Updated 01/20/2011
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1487714960
Products in Payments
- SPRAVATO (Drug) $255.43
- Fanapt (Drug) $148.55
- LATUDA (Drug) $52.17
- REXULTI (Drug) $28.59
- VRAYLAR (Drug) $24.30
- Vyvanse (Drug) $21.33
- RELEXXII (Drug) $20.77
- QUILLIVANT XR (Drug) $18.99
- INGREZZA (Drug) $17.46
- VYVANSE (Drug) $13.31
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Rochester
Mr. Tulio Ortega, Md, MD
Psychiatry — Payments: $246,543
M Ismail, M.d, M.D
Psychiatry — Payments: $50,839
Syed Mustafa, Md, MD
Psychiatry — Payments: $26,048
Peter Jensen, Md, Abpn, MD, ABPN
Psychiatry — Payments: $19,612
Daniel Montville, Md, MD
Psychiatry — Payments: $15,131
Mark Frye, Md, MD
Psychiatry — Payments: $12,930